UTHR - דינמיקת הכנסות משנה לשנה ב-12 החודשים האחרונים United Therapeutics Inc.

United Therapeutics (UTHR) manufacturing facilities in the US ensure the production of unique drugs for rare pathologies. The annual change in sales volume over the LTM demonstrates revenue dynamics, where the current parameter equals 2.00. Growth is driven by leadership in pulmonary hypertension therapy and xenotransplantation, although business resilience depends on patent protection and success in transplantology.
unither.com (UTHR) - פילוחי מדדים ודוחות פיננסיים

To identify fundamentally resilient assets, investors must distinguish market noise from actual revenue dynamics. The TTM annual revenue growth metric measures the percentage change in total sales over the last 12 months, allowing for an assessment of the business expansion rates of United Therapeutics (UTHR) amid risks of losing exclusivity for key drugs and pressure from generics.